Skip to content

LacriCATH LDC315TRecalls & reported problems

Quest Medical Inc · LacriCATH Lacrimal Duct Balloon Catheter, 3 mm. · Class U

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10634624810195), received between Apr 10, 2017 and Apr 10, 2017 — classified as 1 malfunction.

The most frequently reported specific device problem is “Device Operates Differently Than Expected” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Device Operates Differently Than Expected1
  • Inflation Problem1

Patient problems

  • No Known Impact Or Consequence To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionApr 10, 2017Inflation Problem; Device Operates Differently Than Expected

    THE FACILITY MATERIALS MANAGER REPORTED AN ISSUE ENCOUNTERED BY THE PHYSICIAN WHILE USING THE LACRIMAL DUCT CATHETER. THE REPORT STATED THAT THE DEVICE WOULD NOT REMAIN INFLATED. THE REPORT STATED THAT THE CATHETER WAS REMOVED AND A SECOND ONE WAS USED TO SUCCESSFULLY COMPLETE THE PROCEDURE. THERE WERE NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THE ALLEGED ISSUE. THE CATHETER WAS RETURNED TO THE MANUFACTURER FOR EVALUATION.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 6475986 ↗

Other Lacrimal Stents And Intubation Sets devices

All Lacrimal Stents And Intubation Sets devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page